Matthew Gubin, PhD, postdoctoral research scholar in the laboratory of Robert Schreiber, PhD, Alumni Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis, has received a three-year, $164,500 grant from the Cancer Research Institute for research titled “Using Genomics to Identify Targets of Checkpoint Blockade Cancer Treatment and Identify Optimal Target Antigens for Vaccination.”
Latest from the Record
Notables
Sherraden honored as ‘Social Work Pioneer’
Rosa-Molinar named director of cellular imaging center
WashU leader, alumni recognized for commitment to diverse workplaces
Obituaries
Leah Rae Czerniewski, biomedical engineering doctoral student, 34
Ruth Levinsohn Siteman, philanthropist, 92
Stan H. Braude, professor of practice in Arts & Sciences, 62